Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
ACG, a supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, announced the appointment of Gerd Hueffmann as head of global sales and commercial excellence for ACG Engineering.
read more
The global pharmaceutical packaging equipment market is expected to reach $5.1B in 2022. Demand is projected to increase at a robust 8.9% CAGR over the forecast period, pushing the market size to $12B by 2032, according to a report by Future Market Insights.
read more
Ascletis Pharma Inc. announced that the Investigational New Drug (IND) application of ASC10, an oral inhibitor drug candidate targeting RNA-dependent RNA polymerase (RdRp) for Coronavirus Disease 2019 (COVID-19), has been filed to the U.S. Food and Drug Administration (FDA) after the Pre-IND consultation.
read more
The global oral solid dosage contract manufacturing market size is expected to reach $54.7B by 2030, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc.
read more
The global HPAPI market is projected to reach $39.6B by 2027 from $24.5B in 2022, at a CAGR of 10.1% from 2022 to 2027, according to a report from Research & Markets.
read more
Annovis Bio, Inc., a company addressing neurodegenerative diseases, announced that they received notice from the FDA that the Phase 3 clinical study in early Parkinson's patients may proceed.
read more
Sirio Pharma Co., – a global nutraceutical contract development and manufacturing organization (CDMO) – and Best Formulations announced that they have agreed for Sirio to acquire 80% equity of Best, a contract manufacturer of nutraceuticals and dietary supplements based in City of Industry, California.
read more
I Holland, a manufacturer of tablet tooling for the pharmaceutical and nutraceutical markets, has announced the appointment of Borja Guerra as the company’s new Director - Sales and Marketing.
read more
The global herbal supplements market reached a value of$32.1B in 2021, with growth projected to $49.1B by 2027, exhibiting a CAGR of 7.34% during 2021-2027, according to a report from Research & Markets.
read more
Dr. Reddy’s Laboratories Ltd.,launched Dr. Reddy’s Fesoterodine Fumarate Extended-Release Tablets, a therapeutic generic equivalent to Toviaz® (fesoterodine fumarate) Extended-Release Tablets in the U.S. market following the approval by the U.S. Food and Drug Administration (USFDA).
read more
The global Dietary Supplements market size is projected to reach $121110 Million by 2027, from USD 89810 Million in 2020, at a CAGR of 3.9% during 2021-2027, according to Valuates Reports.
read more
Calliditas Therapeutics AB announced that the company has added two members to its management team, Head of Human Resources Sandra Frithiof and Group General Counsel Jonathan Schur.
read more
Gilead Sciences, Inc. announced that Deborah Telman will join the company as Executive Vice President, Corporate Affairs and General Counsel, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day.
read more
W. R. Grace & Co., a producer of specialty silica and fine chemicals, announced it is expanding its contract development and manufacturing (CDMO) facility in South Haven, MI.
The expansion will bring a 4,000-gallon multi-use reactor train consisting of glass-lined and stainless-steel materials of construction.
read more
Piramal Pharma Limited’s Pharma Solutions business, a Contract Development and Manufacturing Organization (CDMO), inaugurated a new active pharmaceutical ingredient (API) plant at the company’s site in Aurora, Ontario.
read more